Ironwood Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on Ironwood Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Ironwood Pharmaceuticals Inc Strategy Report
- Understand Ironwood Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Ironwood Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
04 Nov 2021 | Ironwood Pharma Enters into Licensing Agreement with COUR Pharma | Licensing Agreement |
Ironwood Pharmaceuticals Inc
|
Cour Pharmaceuticals Development Co Inc
|
26 May 2021 | Teva Pharma to Enter into Licensing Agreement with Ironwood Pharma and AbbVie | Licensing Agreement |
Teva Pharmaceuticals USA Inc
|
AbbVie Inc Ironwood Pharmaceuticals Inc |
06 Aug 2019 | Ironwood Pharma Raises USD200 Million in Private Placement of 0.75% Convertible Senior Notes Due 2024 | Debt Offering | - |
Ironwood Pharmaceuticals Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer